Core Viewpoint - The Hong Kong Innovative Drug 50 ETF (513780) experienced a slight increase of 0.53% on November 25, with a trading volume of 432 million yuan, indicating ongoing interest in the innovative drug sector [1] Fund Performance - The fund's latest net asset value is calculated at 3.096 billion yuan, with a total share count of 1.803 billion, reflecting a reduction of 12 million shares on the day and a decrease of 17.5 million shares over the past 20 trading days [1] - Since its inception on October 16, 2024, the fund has achieved a return of 71.74%, although it has seen a slight decline of 0.50% over the past month [1] Management Information - The fund is managed by Invesco Great Wall Fund Management Co., Ltd., with Jin Huang serving as the fund manager [1]
11月25日港股创新药50ETF（513780）份额减少1200.00万份
Xin Lang Cai Jing·2025-11-26 01:13